In a groundbreaking revelation in the world of medical cannabis, German researchers have illuminated the hidden mechanics through which cannabinoids, particularly CBD (cannabidiol), demonstrate potent anti-inflammatory effects. This breakthrough investigation led by the esteemed team at Friedrich-Schiller-Universitaet Jena in Germany, offers an unprecedented insight into how secret allies found in the cannabis plant wage war against inflammation in the human body.
- Groundbreaking research in Germany has illuminated how cannabinoids battle inflammation.
- All studied cannabinoids displayed anti-inflammatory effects, with CBD being the standout ‘peacekeeper’.
- CBD’s effectiveness stems from its ability to activate the 15-lipoxygenase-1 enzyme, kicking off the production of inflammation-ending messenger substances.
- These findings provide novel avenues for future treatments of inflammatory diseases, focusing particularly on CBD.
For years, cannabis has been lauded for its pain-relieving, antispasmodic, and anti-inflammatory attributes, but it wasn’t until now that a scientific pivot arrived, throwing light on its mysterious anti-inflammatory mechanisms. By scrutinizing eight different cannabinoids found in cannabis, including THC (tetrahydrocannabinol) and standout performer, CBD, the researchers have offered an intriguing explanation.
These cannabinoids don’t simply display an anti-inflammatory effect, they actively suppress the formation of inflammation-promoting agents in cells, all the while bolstering the production of inflammation-resolving substances, according to doctoral student Lukas Peltner, a co-author of the study. The yielded results, impressively palatable in all the ‘test’ cannabinoids, highlight CBD as the most potent inflammation-fighting gladiator.
Zooming in on CBD, the team discovered that it indeed rallies the troops, activating the 15-lipoxygenase-1 enzyme which catalyzes the production of inflammation-resolving messenger substances, thereby silencing the inflammation’s wrath. Dr Paul Mike Jordan, the co-author of the study, elucidates: “CBD thus induces a switch in the affected cells, which directs the inflammatory process from the inflammatory-promoting to the inhibiting side.”
Apart from cellular studies, this inflammation-busting prowess of CBD was also replicated in animal experiments involving mice, further solidifying the findings.
Future implications of these findings are profound, potentially heralding novel therapeutic strategies for treating inflammatory diseases, with CBD appearing as the most promising candidate. With the focus pinned on it, CBD is primed to lock horns with inflammation on the battlefield of medical science.
This groundbreaking research was made possible through collaborations with two research centres, namely PolyTarget and ChemBioSys at the University of Jena, Germany, and was generously funded by the German Research Foundation.
What BRITISH CANNABIS™ has to Say:
We’re thrilled to witness monumental steps like this one that continue to bring cannabis, particularly CBD, into the broader realm of recognition and acceptance. The in-depth exploration of the anti-inflammatory mechanisms of cannabinoids and the star performance of CBD in this realm, endorse the exciting potential that this plant has for future therapeutic strategies. The perseverance and dedication showcased by the team at Friedrich-Schiller-Universitaet are much appreciated and further emphasize the importance of such research being rooted in evidence and high-quality science.
For more exciting revelations and insights on this groundbreaking study, visit here.
Stay tuned with BRITISH CANNABIS™ for all your cannabis and CBD news!